Sun Pharma Q2 - Inline
Revenues up 17% at Rs 8123 cr vs Rs 6937 cr (est 8083)
Net profit at Rs 1064 cr vs loss of Rs 269 cr (est 1074)
EBITDA up 17% at Rs 1789 cr vs Rs 1531 cr (est 1675)
Margins at 22.0% vs 22.1% (est 20.7%)
Exceptional loss of Rs 1214 cr in base quarter